AcromegalyNCT01000090
Surgical Versus Medical Treatment of Acromegaly
An observational study of Acromegaly, run by University of Aarhus at 1 site in Denmark.
Trial summary
Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone). Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Acromegaly
- How many people
- 63 participants
- Where
- 1 siteDenmark
- Study dates
- Oct 2009to Jun 2011
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Acromegalic patients followed in the outpatient clinic at Århus University Hospital, Medical Department M
Who may be able to join
- Acromegaly diagnosis
- treated with Somatostatin analogues or surgery
- in treatment control
Who cannot join
- treatment with GH-antagonist
- never treated
- not in treatment control
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers
Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).
Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.
- Conditions
- Acromegaly
- Keywords
- Acromegaly, Somatostatin analogues, Treatment
- Medical subject headings
- Acromegaly
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Acromegaly patients, somatostain analogues | Not described | |
| Acromegaly patients, surgery | Not described |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Oct 2009 (estimated)
- Study startOct 2009
- Primary completionFeb 2010
- Study completionJun 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AcromegalyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 63 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Aarhus
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Kristine Z Rubeck, stud. med., Study director, Medical department M, Århus University HospitalJens Otto L Jørgensen, MD, Principal investigator, Medical department M, Århus University HospitalMichael Madsen, MD, Study director, Medical department M, Århus University HospitalSanne Fisker, MD, Study director, Medical department M, Århus University HospitalCaroline Adreasen, MD, Study director, Medical department M, Århus University HospitalJan Frystyk, MD, Study director, Medical department M, Århus University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01000090
- Sponsor's protocol ID
- kzr200809
- Status last verified
- Jun 2011
- First submitted
- 21 Oct 2009
- Last updated
- 3 Dec 2015
- Results posted
- No
- Data monitoring committee
- No